Towards a sustainable vaccine infrastructure

 

Through the TRANSVAC infrastructure, state-of-the-art scientific-technical services, technical training, and innovative research and development are currently providing very significant support to European vaccine researchers and developers.

TRANSVAC-DS builds on the outstanding success and lessons learned from TRANSVAC and during the two-year project duration will further explore and prepare the establishment of a stable and truly sustainable European vaccine infrastructure. The main objective and output of TRANSVAC-DS is the preparation of a conceptual design report that will describe in detail the maturity of the vaccine infrastructure concept and be the basis for the establishment of a permanent and sustainable vaccine infrastructure of direct relevance to and benefit for Europe and further afield. As part of the design report, a five-year business plan will be delivered together with an implementation plan that will guide the further establishment of a sustainable European vaccine infrastructure.

 

​

Coordination team, European Vaccine Initiative

Hilde Depraetere 

Stefan Jungbluth 

​

Project management team

Monika Slezak

Catarina Luís